Centrfuge integrates symbiotic liquidity, Janus Fund expands to $1.6 billion

Centrifuge expands tokenized fund liquidity: Introducing Symbiotic's Liquid Lane solution

Centrifuge further expands tokenized fund liquidity options by integrating Symbiotic's Liquid Lane into its three funds. Eligible holders can now exchange fund shares for USDC through the on-chain inquiry (RFC) process.

This integration covers Janus Henderson's JAAA (AAA Secured Loan Voucher Strategy), JTRSY (Short-Term U.S. Treasury Bond Strategy) and New York Life Investment Management's HYB (U.S. High-Yield Corporate Bond Strategy). According to the announcement, the total assets under management of these tokenized funds are approximately US$1.6 billion.

Core Points

Centrfuge introduced Symbiotic's Liquid Lane as an additional USDC redemption channel for three tokenized funds, covering loans, treasury bonds and high-yield credit. Liquid Lane adopts an inquiry market model where market makers can withdraw liquidity from vaults to complete redemption requests. The mechanism is designed to allow investors to immediately obtain USDC, while the fund's original standard redemption process operates independently. Felix Lutsch, head of the Symbiotic ecosystem, said Liquid Lane is more focused on optimizing the transaction capital structure and redemption process than the first solution billed as "instant redemption." The move further enriches Centrfuge's existing liquidity arrangements, including paths that have previously been used in JTRSY and HYB.

How Liquid Lane changes Centrfuge's redemption mechanism

Symbiotic's Liquid Lane is built based on the online inquiry market. Eligible holders submit redemption requests, and the market maker responds through inquiry. Unlike traditional models that rely on pre-configured inventories, Liquid Lane allows participating liquidity providers to call liquidity from vaults to meet redemption needs. After the market maker obtains fund tokens through inquiry and settlement, it can obtain redemption of underlying assets through the issuer, or reconfigure the position through another inquiry transaction. Centrifuge's goal is to give investors instant access to USDC while allowing funds to complete the standard redemption process at their own pace.

Funds that have been launched: JAAA, JTRSY and HYB

The Symbiotic path has been applied to three tokenized funds issued by Centrfuge: Janus Henderson's JAAA focuses on exposure to AAA secured loan certificates, JTRSY focuses on short-term U.S. Treasury strategies, and New York Life Investment Management's HYB provides exposure to U.S. high-yield corporate bonds. For investors, the practical significance lies in breadth: the Liquid Lane path covers assets with different credit ratings and duration characteristics. This is particularly important in the tokenized fund market-different asset types have different liquidity requirements, and some participants view tokenized funds as income products or as an integral part of the on-chain collateral and financing process.

Not the first path-Focus on Capital Economics

Liquid Lane is not Centrfuge's first liquidity path. Felix Lutsch, head of the Symbiotic ecosystem, said the company has no intention of claiming to be an early and exclusive provider of instant redemption capabilities. "We don't claim to be pioneers. There are other liquidity paths in the market, which is healthy for the entire market." Lutsch said. In early 2025, Centrifuge announced a partnership with Wintermute to provide JTRSY with round-the-clock instant redemption services. HYB was also equipped with a separate liquidity arrangement when it launched in June, designed to achieve near-instant redemptions.

Lutsch points out that the differentiation of Liquid Lane lies in the underlying capital structure that supports redemption transactions, not just the speed of settlement. He described a market design that allows multiple market makers and custodians to participate, without each market maker having to fund specific assets in advance and hold inventory. In Lutsch's view, this accurately targets the core market issue: the long-term low trading volume of tokenized assets has weakened the willingness of liquidity providers to invest capital. "The bigger constraint has always been liquidity," Lutsch said, pointing to the challenge of building continued redemption demand in the tokenized market.

Why is aggregated redemption demand important

Lutsch believes that aggregating redemption demand across issuers and asset classes can improve liquidity economics-especially as tokenized funds are increasingly used as collateral and financing assets in on-chain markets. This framework connects current integration efforts to a broader trend: when contemporary monetized funds are no longer just independent investment vehicles, but become building blocks for on-chain lending, collateral management, and other structured finance use cases, liquidity is no longer dependent on a single redemption, but more dependent on sustained transaction throughput under changing market conditions. In this context, the additional liquidity path is more than just an iteration of product functionality. They can reduce friction for holders to quickly exit positions and help liquidity providers manage risk exposure more efficiently in shared markets, rather than relying on exclusive inventories for each asset.

How strong is Centrfuge's push?

Janus Henderson has been a major driver of Centrfuge's growth. Previous reports have shown that Janus Henderson's JAAA and JTRSY products helped Centrfuge's total locked value exceed US$1 billion. Token Terminal data shows that as of December 2025, Centrifuge has attracted approximately US$1.3 billion in new capital inflows, mainly from Janus Henderson's two funds. Among them, JAAA alone contributed approximately US$1 billion in total lockup value and is described as one of the largest tokenized funds on the market. With Liquid Lane now integrated into JAAA, JTRSY and HYB, the integration is actually targeting three sizable strategies in the Centrfuge ecosystem, rather than testing liquidity paths on small positions.

Future Focus

As Centrfuge expands its liquidity path through Symbiotic and other counterparties, investors should pay attention to whether the USDC settlement mechanism based on inquiry will continue to be adopted as redemptions grow; and whether the scope of market makers 'participation will further expand beyond the few active liquidity providers in tokenized funds.